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Abstract	 ﾠ
	 ﾠ
Background	 ﾠ
Effective	 ﾠmanagement	 ﾠof	 ﾠchronic	 ﾠdiseases	 ﾠsuch	 ﾠas	 ﾠprostate	 ﾠ
cancer	 ﾠis	 ﾠimportant.	 ﾠResearch	 ﾠsuggests	 ﾠa	 ﾠtendency	 ﾠto	 ﾠuse	 ﾠ
self-ﾭ‐care	 ﾠtreatment	 ﾠoptions	 ﾠsuch	 ﾠas	 ﾠover-ﾭ‐the-ﾭ‐counter	 ﾠ(OTC)	 ﾠ
complementary	 ﾠ medications	 ﾠ among	 ﾠ prostate	 ﾠ cancer	 ﾠ
patients.	 ﾠThe	 ﾠcurrent	 ﾠtrend	 ﾠin	 ﾠpatient-ﾭ‐driven	 ﾠrecording	 ﾠof	 ﾠ
health	 ﾠ data	 ﾠ in	 ﾠ an	 ﾠ online	 ﾠ Personal	 ﾠ Health	 ﾠ Record	 ﾠ (PHR)	 ﾠ
presents	 ﾠ an	 ﾠ opportunity	 ﾠ to	 ﾠ develop	 ﾠ new	 ﾠ data-ﾭ‐driven	 ﾠ
approaches	 ﾠ for	 ﾠ improving	 ﾠ prostate	 ﾠ cancer	 ﾠ patient	 ﾠ care.	 ﾠ
However,	 ﾠ the	 ﾠ ability	 ﾠ of	 ﾠ current	 ﾠ online	 ﾠ solutions	 ﾠ to	 ﾠ share	 ﾠ
patients’	 ﾠ data	 ﾠ for	 ﾠ better	 ﾠ decision	 ﾠ support	 ﾠ is	 ﾠ limited.	 ﾠ An	 ﾠ
informatics	 ﾠ approach	 ﾠmay	 ﾠimprove	 ﾠonline	 ﾠsharing	 ﾠof	 ﾠself-ﾭ‐
care	 ﾠinterventions	 ﾠamong	 ﾠthese	 ﾠpatients.	 ﾠIt	 ﾠcan	 ﾠalso	 ﾠprovide	 ﾠ
better	 ﾠevidence	 ﾠto	 ﾠsupport	 ﾠdecisions	 ﾠmade	 ﾠduring	 ﾠtheir	 ﾠself-ﾭ‐
managed	 ﾠcare.	 ﾠ	 ﾠ	 ﾠ
Aims	 ﾠ
To	 ﾠidentify	 ﾠrequirements	 ﾠfor	 ﾠan	 ﾠonline	 ﾠsystem	 ﾠand	 ﾠdescribe	 ﾠ
a	 ﾠ new	 ﾠ case-ﾭ‐based	 ﾠ reasoning	 ﾠ (CBR)	 ﾠ method	 ﾠ for	 ﾠ improving	 ﾠ
self-ﾭ‐care	 ﾠof	 ﾠadvanced	 ﾠprostate	 ﾠcancer	 ﾠpatients	 ﾠin	 ﾠan	 ﾠonline	 ﾠ
PHR	 ﾠenvironment.	 ﾠ
Method	 ﾠ	 ﾠ	 ﾠ
A	 ﾠ non-ﾭ‐identifying	 ﾠ online	 ﾠ survey	 ﾠ was	 ﾠ conducted	 ﾠ to	 ﾠ
understand	 ﾠ self-ﾭ‐care	 ﾠ patterns	 ﾠa m o n g 	 ﾠp r o s t a t e 	 ﾠc a n c e r 	 ﾠ
patients	 ﾠ and	 ﾠ to	 ﾠ identify	 ﾠ requirements	 ﾠ for	 ﾠ an	 ﾠ online	 ﾠ
information	 ﾠ system.	 ﾠ The	 ﾠ pilot	 ﾠ study	 ﾠ was	 ﾠ carried	 ﾠ out	 ﾠ
between	 ﾠAugust	 ﾠ2010	 ﾠand	 ﾠDecember	 ﾠ2010.	 ﾠA	 ﾠcase-ﾭ‐base	 ﾠof	 ﾠ	 ﾠ
52	 ﾠpatients	 ﾠwas	 ﾠdeveloped.	 ﾠ	 ﾠ
	 ﾠ
	 ﾠ
Results	 ﾠ
The	 ﾠ data	 ﾠ analysis	 ﾠ showed	 ﾠ self-ﾭ‐care	 ﾠ patterns	 ﾠ among	 ﾠ the	 ﾠ
prostate	 ﾠcancer	 ﾠpatients.	 ﾠ	 ﾠSelenium	 ﾠ(55%)	 ﾠwas	 ﾠthe	 ﾠcommon	 ﾠ
complementary	 ﾠ supplement	 ﾠu s e d 	 ﾠb y 	 ﾠt h e 	 ﾠp a t i e n t s . 	 ﾠ
Paracetamol	 ﾠ(about	 ﾠ45%)	 ﾠwas	 ﾠthe	 ﾠcommonly	 ﾠused	 ﾠOTC	 ﾠby	 ﾠ
the	 ﾠpatients.	 ﾠ
Conclusion	 ﾠ
The	 ﾠ results	 ﾠ of	 ﾠ this	 ﾠ study	 ﾠ specified	 ﾠ requirements	 ﾠ for	 ﾠ an	 ﾠ
online	 ﾠ case-ﾭ‐based	 ﾠ reasoning	 ﾠ information	 ﾠ system.	 ﾠ The	 ﾠ
outcomes	 ﾠof	 ﾠthis	 ﾠstudy	 ﾠare	 ﾠbeing	 ﾠincorporated	 ﾠin	 ﾠdesign	 ﾠof	 ﾠ
the	 ﾠ proposed	 ﾠ Artificial	 ﾠ Intelligence	 ﾠ (AI)	 ﾠd r i v e n 	 ﾠp a t i e n t 	 ﾠ
journey	 ﾠbrowser	 ﾠsystem.	 ﾠA	 ﾠbasic	 ﾠversion	 ﾠof	 ﾠthe	 ﾠproposed	 ﾠ
system	 ﾠis	 ﾠcurrently	 ﾠbeing	 ﾠconsidered	 ﾠfor	 ﾠimplementation.	 ﾠ
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What	 ﾠthis	 ﾠstudy	 ﾠadds:	 ﾠ
1.  This	 ﾠ study	 ﾠ reports	 ﾠ self-ﾭ‐care	 ﾠ pattern	 ﾠ among	 ﾠ advanced	 ﾠ
prostate	 ﾠ cancer	 ﾠ patients	 ﾠ by	 ﾠ conducting	 ﾠ a	 ﾠ survey	 ﾠa n d 	 ﾠ
specifies	 ﾠthe	 ﾠrequirements	 ﾠfor	 ﾠan	 ﾠonline	 ﾠsystem	 ﾠbased	 ﾠ
upon	 ﾠsurvey	 ﾠfindings	 ﾠand	 ﾠdata	 ﾠanalysis.	 ﾠ	 ﾠ
2.  This	 ﾠ study	 ﾠd e s c r i b e s	 ﾠa 	 ﾠc a s e -ﾭ‐based	 ﾠ reasoning	 ﾠ approach	 ﾠ
for	 ﾠimproving	 ﾠaccessible	 ﾠdecision	 ﾠsupport	 ﾠinformation	 ﾠto	 ﾠ
the	 ﾠpatients	 ﾠin	 ﾠan	 ﾠonline	 ﾠPHR	 ﾠenvironment.	 ﾠ	 ﾠ
3.  This	 ﾠstudy	 ﾠaims	 ﾠto	 ﾠmake	 ﾠa	 ﾠcontribution	 ﾠto	 ﾠthe	 ﾠpatient-ﾭ‐
driven	 ﾠonline	 ﾠhealth	 ﾠdata	 ﾠsharing	 ﾠsolutions.	 ﾠ
	 ﾠ
	 ﾠ
Background	 ﾠ
Prostate	 ﾠ cancer	 ﾠ is	 ﾠ one	 ﾠ of	 ﾠ the	 ﾠ causes	 ﾠo f 	 ﾠm a l e 	 ﾠd e a t h 	 ﾠi n 	 ﾠ
Australia.
1	 ﾠProstate	 ﾠcancer	 ﾠwas	 ﾠthe	 ﾠmost	 ﾠnewly	 ﾠdiagnosed	 ﾠ
cancer	 ﾠwith	 ﾠ19,403	 ﾠcases	 ﾠdiagnosed	 ﾠin	 ﾠ2007.
2	 ﾠDue	 ﾠto	 ﾠthe	 ﾠ
chronic	 ﾠnature	 ﾠof	 ﾠthe	 ﾠdisease,	 ﾠit	 ﾠis	 ﾠdifficult to	 ﾠunderstand	 ﾠ
the	 ﾠ journey	 ﾠ of	 ﾠ patients	 ﾠ especially	 ﾠ those	 ﾠ who	 ﾠ are	 ﾠ at	 ﾠ an	 ﾠ
advanced	 ﾠ stage.	 ﾠ The	 ﾠ journey	 ﾠ of	 ﾠ prostate	 ﾠ cancer	 ﾠ can	 ﾠ be	 ﾠ
described	 ﾠ using	 ﾠ the	 ﾠ various	 ﾠ treatment	 ﾠ points	 ﾠa s 	 ﾠe v e n t s .
3	 ﾠ
Patients	 ﾠalso	 ﾠuses	 ﾠseveral	 ﾠcomplementary	 ﾠsupplements	 ﾠand	 ﾠ
OTC	 ﾠm e d i c a t i o n s . 	 ﾠI t 	 ﾠi s 	 ﾠi m p o r t a n t 	 ﾠt o 	 ﾠu n d e r s t a n d 	 ﾠs e l f -ﾭ‐care	 ﾠ
patterns	 ﾠ of	 ﾠ advanced	 ﾠ prostate	 ﾠ cancer	 ﾠ patients	 ﾠ with	 ﾠ
alternative	 ﾠ therapies	 ﾠ and	 ﾠ OTC	 ﾠ medications.	 ﾠ It	 ﾠ is	 ﾠ also	 ﾠ
important	 ﾠto	 ﾠinvestigate	 ﾠthe	 ﾠeffect	 ﾠof	 ﾠcollaboration	 ﾠamong	 ﾠ
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 ﾠ
patients	 ﾠat	 ﾠvarious	 ﾠstages	 ﾠof	 ﾠthe	 ﾠadvanced	 ﾠprostate	 ﾠcancer	 ﾠ
journey.	 ﾠ We	 ﾠ conducted	 ﾠ a	 ﾠ survey	 ﾠ for	 ﾠ observing	 ﾠ self-ﾭ‐care	 ﾠ
pattern	 ﾠ among	 ﾠ advanced	 ﾠ prostate	 ﾠ cancer	 ﾠ patients.	 ﾠ We	 ﾠ
applied	 ﾠthe	 ﾠsurvey	 ﾠfindings	 ﾠto	 ﾠspecify	 ﾠrequirements	 ﾠfor	 ﾠan	 ﾠ
online	 ﾠ system	 ﾠ and	 ﾠ described	 ﾠa 	 ﾠc a s e -ﾭ‐based	 ﾠ reasoning	 ﾠ
approach	 ﾠto	 ﾠimprove	 ﾠpatient	 ﾠcare	 ﾠin	 ﾠan	 ﾠonline	 ﾠcollaborative	 ﾠ
PHR	 ﾠenvironment.	 ﾠThe	 ﾠresearch	 ﾠsuggests	 ﾠa	 ﾠtrend	 ﾠin	 ﾠonline	 ﾠ
sharing	 ﾠ of	 ﾠ patient	 ﾠ health	 ﾠ data	 ﾠ for	 ﾠ better	 ﾠ information	 ﾠ to	 ﾠ
patients.
4	 ﾠO u r 	 ﾠr e s e a r c h 	 ﾠa i m s	 ﾠ to	 ﾠ leverage	 ﾠ this	 ﾠ trend	 ﾠ to	 ﾠ
facilitate	 ﾠ evidence-ﾭ‐based	 ﾠ decision	 ﾠ support	 ﾠ for	 ﾠ advanced	 ﾠ
prostate	 ﾠcancer	 ﾠpatients.	 ﾠCase-ﾭ‐based	 ﾠreasoning	 ﾠ(CBR)	 ﾠis	 ﾠa	 ﾠ
widely	 ﾠused	 ﾠapproach	 ﾠfor	 ﾠknowledge	 ﾠrepresentation	 ﾠin	 ﾠAI	 ﾠ
driven	 ﾠ applications.
5-ﾭ‐8	 ﾠW e 	 ﾠh a v e 	 ﾠp r o p o s e d 	 ﾠa 	 ﾠc a s e -ﾭ‐based	 ﾠ
reasoning	 ﾠ approach	 ﾠ to	 ﾠ model	 ﾠ the	 ﾠ problem-ﾭ‐solution-ﾭ‐
outcome	 ﾠ combination	 ﾠ at	 ﾠ various	 ﾠ stages	 ﾠ of	 ﾠ the	 ﾠ prostate	 ﾠ
cancer	 ﾠjourney.	 ﾠ
	 ﾠ
Methods	 ﾠ
This	 ﾠresearch	 ﾠconducted	 ﾠa	 ﾠsurvey	 ﾠusing	 ﾠa	 ﾠcarefully	 ﾠdesigned	 ﾠ
questionnaire.	 ﾠ The	 ﾠ non-ﾭ‐identifying	 ﾠ questionnaire	 ﾠ was	 ﾠ
designed	 ﾠto	 ﾠunderstand	 ﾠthe	 ﾠcare	 ﾠneeds	 ﾠof	 ﾠthe	 ﾠpatients	 ﾠwith	 ﾠ
advanced	 ﾠprostate	 ﾠcancer.	 ﾠThe	 ﾠsurvey	 ﾠwas	 ﾠdesigned	 ﾠusing	 ﾠ
the	 ﾠ categories	 ﾠ such	 ﾠ as	 ﾠ demographics	 ﾠ (e.g.	 ﾠ age	 ﾠ group),	 ﾠ
prostate	 ﾠ cancer	 ﾠs t a g e , 	 ﾠc are	 ﾠ provider,	 ﾠ treatment,	 ﾠ
medications,	 ﾠcomplementary	 ﾠor	 ﾠalternative	 ﾠtherapy,	 ﾠdietary	 ﾠ
supplements,	 ﾠ non-ﾭ‐prescribed	 ﾠ OTC	 ﾠ medications	 ﾠ and	 ﾠ
prescribed	 ﾠmedications.	 ﾠThe	 ﾠquestionnaire	 ﾠwas	 ﾠdistributed	 ﾠ
to	 ﾠ patients	 ﾠ through	 ﾠ prostate	 ﾠ cancer	 ﾠ support	 ﾠ groups.	 ﾠ The	 ﾠ
data	 ﾠcollection	 ﾠperiod	 ﾠwas	 ﾠfrom	 ﾠAugust	 ﾠ2010	 ﾠto	 ﾠDecember	 ﾠ
2010.	 ﾠThe	 ﾠdata	 ﾠwas	 ﾠcollected	 ﾠusing	 ﾠan	 ﾠonline	 ﾠversion	 ﾠof	 ﾠthe	 ﾠ
questionnaire	 ﾠ as	 ﾠ well	 ﾠ as	 ﾠ a	 ﾠ paper	 ﾠ version.	 ﾠ A	 ﾠ total	 ﾠ of	 ﾠ 52	 ﾠ
patients	 ﾠparticipated	 ﾠin	 ﾠthe	 ﾠpilot	 ﾠstudy.	 ﾠThe	 ﾠdata	 ﾠcollected	 ﾠin	 ﾠ
this	 ﾠpilot	 ﾠstudy	 ﾠwas	 ﾠused	 ﾠto	 ﾠanswer	 ﾠthe	 ﾠfollowing	 ﾠresearch	 ﾠ
questions:	 ﾠ
1.  How	 ﾠmany	 ﾠpatients	 ﾠhave	 ﾠever	 ﾠused	 ﾠa	 ﾠcomplementary,	 ﾠ
alternative	 ﾠ therapy	 ﾠ or	 ﾠ dietary	 ﾠ supplements	 ﾠ during	 ﾠ or	 ﾠ
after	 ﾠconventional	 ﾠprostate	 ﾠcancer	 ﾠtreatment?	 ﾠ	 ﾠ
2.  What	 ﾠ is	 ﾠ the	 ﾠ most	 ﾠ common	 ﾠ OTC	 ﾠ drug	 ﾠ used	 ﾠ by	 ﾠt h e s e 	 ﾠ
patients?	 ﾠ	 ﾠ
3.  What	 ﾠ are	 ﾠ the	 ﾠ co-ﾭ‐morbidities	 ﾠ in	 ﾠ advanced	 ﾠ prostate	 ﾠ
cancer	 ﾠpatients?	 ﾠ
	 ﾠ
Results	 ﾠ	 ﾠ
The	 ﾠ survey	 ﾠ findings	 ﾠ showed	 ﾠ that	 ﾠ 59.62%	 ﾠ of	 ﾠ participants	 ﾠ
used	 ﾠ a	 ﾠ complementary,	 ﾠ alternative	 ﾠ therapy	 ﾠ or	 ﾠ dietary	 ﾠ
supplement	 ﾠ during	 ﾠ or	 ﾠ after	 ﾠ conventional	 ﾠ prostate	 ﾠ cancer	 ﾠ
treatment.	 ﾠ Green	 ﾠ tea,	 ﾠ selenium	 ﾠ (55%)	 ﾠ and	 ﾠ tomatoes	 ﾠ and	 ﾠ
lycopene	 ﾠwere	 ﾠthe	 ﾠmost	 ﾠcommonly	 ﾠused	 ﾠas	 ﾠa	 ﾠdietary	 ﾠintake;	 ﾠ
49%	 ﾠ of	 ﾠ patients	 ﾠ did	 ﾠ not	 ﾠ use	 ﾠ any	 ﾠ non-ﾭ‐prescribed	 ﾠ OTC	 ﾠ
medications.	 ﾠ Patient	 ﾠ who	 ﾠ used	 ﾠ any	 ﾠ OTC	 ﾠ medication	 ﾠ
commonly	 ﾠ used	 ﾠ paracetamol	 ﾠ (45%).	 ﾠ High	 ﾠ blood	 ﾠ pressure	 ﾠ
was	 ﾠ the	 ﾠ most	 ﾠ common	 ﾠ co-ﾭ‐morbidity	 ﾠ among	 ﾠ the	 ﾠ patients.	 ﾠ
The	 ﾠanalysis	 ﾠof	 ﾠpatient	 ﾠresponse	 ﾠin	 ﾠthis	 ﾠstudy	 ﾠshowed	 ﾠthat	 ﾠ
88%	 ﾠ of	 ﾠ patients	 ﾠ were	 ﾠ willing	 ﾠ to	 ﾠ participate	 ﾠ in	 ﾠ a	 ﾠ suitable	 ﾠ
clinical	 ﾠ trial.	 ﾠ The	 ﾠ analysis	 ﾠ of	 ﾠ age-ﾭ‐related	 ﾠ patient	 ﾠ
demographics	 ﾠshows	 ﾠthat	 ﾠthe	 ﾠpercentage	 ﾠof	 ﾠpatients	 ﾠaged	 ﾠ
greater	 ﾠthan	 ﾠ60	 ﾠyears	 ﾠwas	 ﾠ88%.	 ﾠThe	 ﾠcomparison	 ﾠof	 ﾠthe	 ﾠage-ﾭ‐
related	 ﾠ patient	 ﾠ demographics	 ﾠ with	 ﾠ population-ﾭ‐based	 ﾠ
findings	 ﾠspecified	 ﾠin	 ﾠthe	 ﾠreport	 ﾠby	 ﾠthe	 ﾠAustralian	 ﾠInstitute	 ﾠof	 ﾠ
Health	 ﾠand	 ﾠWelfare
9	 ﾠconfirms	 ﾠthat	 ﾠcancer	 ﾠincidence	 ﾠrate	 ﾠis	 ﾠ
higher	 ﾠin	 ﾠpatients	 ﾠaged	 ﾠ60	 ﾠyears	 ﾠand	 ﾠabove	 ﾠ(mean	 ﾠage	 ﾠ68.4	 ﾠ
for	 ﾠ2007).	 ﾠThese	 ﾠsurvey	 ﾠresults	 ﾠformed	 ﾠthe	 ﾠfoundation	 ﾠof	 ﾠ
our	 ﾠ proposed	 ﾠ technology	 ﾠ based	 ﾠ intervention	 ﾠ to	 ﾠ improve	 ﾠ
prostate	 ﾠ cancer	 ﾠ health	 ﾠ outcomes.	 ﾠ Our	 ﾠ proposed	 ﾠ system	 ﾠ
leverages	 ﾠtrends	 ﾠin	 ﾠonline	 ﾠhealth	 ﾠdata	 ﾠsharing.	 ﾠ	 ﾠ
 
Discussion	 ﾠ
Mapping	 ﾠto	 ﾠthe	 ﾠresults	 ﾠof	 ﾠthe	 ﾠsurvey	 ﾠ
The	 ﾠsurvey	 ﾠresults	 ﾠprovided	 ﾠan	 ﾠinsight	 ﾠto	 ﾠvarious	 ﾠtreatments	 ﾠ
undertaken	 ﾠby	 ﾠthe	 ﾠadvanced	 ﾠprostate	 ﾠcancer	 ﾠpatients.	 ﾠThe	 ﾠ
analysis	 ﾠof	 ﾠthe	 ﾠsurvey	 ﾠresults	 ﾠsuggested	 ﾠa	 ﾠself-ﾭ‐care	 ﾠpattern	 ﾠ
among	 ﾠ advanced	 ﾠ prostate	 ﾠ cancer	 ﾠ patients	 ﾠ and	 ﾠ showed	 ﾠ a	 ﾠ
practice	 ﾠ of	 ﾠ self-ﾭ‐reporting	 ﾠ about	 ﾠ the	 ﾠ complementary	 ﾠ and	 ﾠ
OTC	 ﾠmedications.	 ﾠThe	 ﾠsurvey	 ﾠresults	 ﾠshowed	 ﾠthat	 ﾠthe	 ﾠself-ﾭ‐
care	 ﾠ interventions	 ﾠ undertaken	 ﾠ by	 ﾠ the	 ﾠ patients	 ﾠ are	 ﾠ an	 ﾠ
integral	 ﾠ part	 ﾠ of	 ﾠ understanding	 ﾠ their	 ﾠ journey.	 ﾠ The	 ﾠ patient	 ﾠ
reported	 ﾠdata	 ﾠshould	 ﾠbe	 ﾠintegrated	 ﾠwith	 ﾠappropriate	 ﾠclinical	 ﾠ
treatment	 ﾠ interventions	 ﾠ undertaken	 ﾠ and	 ﾠ such	 ﾠ integration	 ﾠ
will	 ﾠenable	 ﾠa	 ﾠholistic	 ﾠunderstanding	 ﾠof	 ﾠadvanced	 ﾠprostate	 ﾠ
cancer	 ﾠpatient’s	 ﾠclinical	 ﾠjourney.	 ﾠ	 ﾠ
	 ﾠ
Rationale	 ﾠ–	 ﾠarbitrary	 ﾠ	 ﾠ
A	 ﾠpatient	 ﾠjourney	 ﾠis	 ﾠcommonly	 ﾠrepresented	 ﾠas	 ﾠa	 ﾠwork	 ﾠflow	 ﾠ
of	 ﾠ patients	 ﾠ from	 ﾠ various	 ﾠ health	 ﾠ service	 ﾠ providers.	 ﾠ 	 ﾠ Our	 ﾠ
research	 ﾠ into	 ﾠ existing	 ﾠ methods	 ﾠ and	 ﾠ tools	 ﾠ shows	 ﾠ that	 ﾠ the	 ﾠ
existing	 ﾠsystems	 ﾠmainly	 ﾠfocus	 ﾠon	 ﾠwork	 ﾠflow	 ﾠand	 ﾠdata	 ﾠflow	 ﾠ
arising	 ﾠout	 ﾠof	 ﾠthe	 ﾠwork	 ﾠflow	 ﾠrelated	 ﾠto	 ﾠa	 ﾠparticular	 ﾠhealth	 ﾠ
care	 ﾠ setting.
10,11	 ﾠT h e s e 	 ﾠs y s t e m s 	 ﾠa r e 	 ﾠa p p r o p r i a t e 	 ﾠf o r 	 ﾠ
enhancing	 ﾠbusiness	 ﾠprocesses	 ﾠinvolved	 ﾠin	 ﾠproviding	 ﾠcare	 ﾠto	 ﾠ
the	 ﾠprostate	 ﾠcancer	 ﾠpatients.	 ﾠHowever,	 ﾠclinical	 ﾠdecisions	 ﾠcan	 ﾠ
be	 ﾠmade	 ﾠusing	 ﾠa	 ﾠmore	 ﾠgranular	 ﾠlevel	 ﾠof	 ﾠpatient	 ﾠdata	 ﾠthat	 ﾠ
integrates	 ﾠ their	 ﾠ clinical	 ﾠ treatment	 ﾠ information	 ﾠ with	 ﾠ self-ﾭ‐
administered	 ﾠ intervention.	 ﾠ The	 ﾠ information	 ﾠ presented	 ﾠ to	 ﾠ
the	 ﾠdecision	 ﾠmakers	 ﾠincluding	 ﾠcarers	 ﾠas	 ﾠwell	 ﾠas	 ﾠpatients	 ﾠcan	 ﾠ
be	 ﾠenhanced	 ﾠat	 ﾠa	 ﾠfiner	 ﾠlevel	 ﾠof	 ﾠdisease-ﾭ‐specific	 ﾠdetails.	 ﾠIn	 ﾠ
the	 ﾠcontext	 ﾠof	 ﾠself-ﾭ‐management	 ﾠof	 ﾠthe	 ﾠdisease	 ﾠconditions,	 ﾠ
the	 ﾠ patient	 ﾠ data	 ﾠ should	 ﾠ be	 ﾠ aggregated	 ﾠ and	 ﾠ presented	 ﾠ to	 ﾠ
empower	 ﾠ the	 ﾠp a t i e n t s . 	 ﾠA 	 ﾠs e l f -ﾭ‐management	 ﾠ solution	 ﾠ for	 ﾠ
advanced	 ﾠprostate	 ﾠcancer	 ﾠpatients	 ﾠcan	 ﾠprovide	 ﾠthem	 ﾠwith	 ﾠa	 ﾠ
better	 ﾠunderstanding	 ﾠof	 ﾠtheir	 ﾠdisease	 ﾠprogression.	 ﾠThere	 ﾠis	 ﾠa	 ﾠ
need	 ﾠfor	 ﾠa	 ﾠnew	 ﾠperspective	 ﾠtowards	 ﾠmodelling	 ﾠthe	 ﾠpatient	 ﾠ
journey.	 ﾠ A	 ﾠ patient’s	 ﾠ journey	 ﾠ can	 ﾠ be	 ﾠ described	 ﾠ in	 ﾠ various	 ﾠ
health	 ﾠ states.	 ﾠ The	 ﾠ health	 ﾠ states	 ﾠ can	 ﾠ be	 ﾠ represented	 ﾠ by	 ﾠ
specific	 ﾠ stages	 ﾠ of	 ﾠ advanced	 ﾠ prostate	 ﾠ cancer	 ﾠ progression.	 ﾠ	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The	 ﾠjourney	 ﾠof	 ﾠmen	 ﾠdiagnosed	 ﾠwith	 ﾠprostate	 ﾠcancer	 ﾠcan	 ﾠbe	 ﾠ
described	 ﾠ in	 ﾠ various	 ﾠ health	 ﾠ states	 ﾠ (HS)	 ﾠ such	 ﾠ as	 ﾠ localised	 ﾠ
prostate	 ﾠcancer,	 ﾠlocally	 ﾠadvanced	 ﾠprostate	 ﾠcancer	 ﾠand	 ﾠother	 ﾠ
advanced	 ﾠstages	 ﾠof	 ﾠthe	 ﾠdisease.	 ﾠEach	 ﾠhealth	 ﾠstate	 ﾠcan	 ﾠbe	 ﾠ
characterised	 ﾠ by	 ﾠ specific	 ﾠ clinical	 ﾠ treatments,	 ﾠ health	 ﾠ
outcomes	 ﾠ achieved	 ﾠ and	 ﾠ any	 ﾠ prostate	 ﾠ cancer-ﾭ‐specific	 ﾠ side	 ﾠ
effects	 ﾠ including	 ﾠ mental	 ﾠ health	 ﾠ disorders	 ﾠ such	 ﾠ as	 ﾠ anxiety	 ﾠ
and	 ﾠ depression.	 ﾠO u r 	 ﾠr e s e a r c h 	 ﾠa b o u t 	 ﾠe x i s t i n g 	 ﾠo n l i n e 	 ﾠ
information	 ﾠ resources	 ﾠ for	 ﾠ self-ﾭ‐managed	 ﾠ care	 ﾠ of	 ﾠ advanced	 ﾠ
prostate	 ﾠ cancer	 ﾠhas	 ﾠ found	 ﾠ that	 ﾠ the	 ﾠ information	 ﾠ is	 ﾠ mainly	 ﾠ
static	 ﾠand	 ﾠis	 ﾠof	 ﾠgeneric	 ﾠnature.	 ﾠThe	 ﾠprostate	 ﾠcancer	 ﾠsurvivors	 ﾠ
need	 ﾠ to	 ﾠ process	 ﾠ vast	 ﾠ amount	 ﾠ of	 ﾠ generic	 ﾠ information	 ﾠ
themselves	 ﾠ and	 ﾠ they	 ﾠ frequently	 ﾠ have	 ﾠ to	 ﾠ depend	 ﾠ on	 ﾠ their	 ﾠ
care	 ﾠproviders	 ﾠfor	 ﾠtheir	 ﾠpersonalised	 ﾠinformation.	 ﾠThere	 ﾠis	 ﾠ
no	 ﾠ clear	 ﾠ evidence	 ﾠ to	 ﾠ suggest	 ﾠ these	 ﾠ existing	 ﾠ methods	 ﾠ and	 ﾠ
ways	 ﾠ of	 ﾠ distributing	 ﾠ information	 ﾠ to	 ﾠ prostate	 ﾠ cancer	 ﾠ
survivors	 ﾠ are	 ﾠ effective	 ﾠ from	 ﾠ health	 ﾠ outcomes	 ﾠ and	 ﾠ health	 ﾠ
economics	 ﾠ perspectives.	 ﾠ Therefore,	 ﾠ there	 ﾠ is	 ﾠ a	 ﾠ need	 ﾠ for	 ﾠ
information	 ﾠ solutions	 ﾠ that	 ﾠ are	 ﾠ more	 ﾠ adaptable	 ﾠ and	 ﾠ
personalised	 ﾠto	 ﾠempower	 ﾠprostate	 ﾠcancer	 ﾠsurvivors	 ﾠto	 ﾠtake	 ﾠ
action	 ﾠfor	 ﾠmanaging	 ﾠtheir	 ﾠown	 ﾠhealth	 ﾠespecially	 ﾠduring	 ﾠtheir	 ﾠ
rehabilitation.	 ﾠ The	 ﾠ proposed	 ﾠ solution	 ﾠ will	 ﾠ add	 ﾠ value	 ﾠ to	 ﾠ
Prostate	 ﾠ cancer	 ﾠs u r v i v o r s 	 ﾠb y 	 ﾠp r o v i d i n g 	 ﾠp e r s o n a l i s e d 	 ﾠ
information	 ﾠ to	 ﾠ take	 ﾠ actions	 ﾠ for	 ﾠ their	 ﾠ self-ﾭ‐managed	 ﾠ care	 ﾠ
especially	 ﾠduring	 ﾠtheir	 ﾠrehabilitation.	 ﾠBased	 ﾠon	 ﾠthe	 ﾠfindings	 ﾠ
of	 ﾠ our	 ﾠ survey,	 ﾠ a	 ﾠ research	 ﾠ prototype	 ﾠ was	 ﾠ developed	 ﾠ to	 ﾠ
describe	 ﾠ sharing	 ﾠ of	 ﾠ complementary	 ﾠ medication	 ﾠ outcomes	 ﾠ
among	 ﾠ prostate	 ﾠ cancer	 ﾠ patients.	 ﾠ The	 ﾠ purpose	 ﾠ of	 ﾠ the	 ﾠ
research	 ﾠ prototype	 ﾠ is	 ﾠ to	 ﾠ demonstrate	 ﾠ efficient	 ﾠ use	 ﾠ of	 ﾠ an	 ﾠ
online	 ﾠ Personal	 ﾠ Health	 ﾠ Record	 ﾠ (PHR)	 ﾠ solution	 ﾠa n d 	 ﾠs e l f -ﾭ‐
reported	 ﾠdata	 ﾠby	 ﾠthe	 ﾠpatients.	 ﾠIt	 ﾠis	 ﾠassumed	 ﾠthat	 ﾠthe	 ﾠonline	 ﾠ
PHR	 ﾠsolution	 ﾠwill	 ﾠallow	 ﾠpatients	 ﾠto	 ﾠrecord	 ﾠdata	 ﾠinto	 ﾠtheir	 ﾠ
clinical	 ﾠrecord.	 ﾠThe	 ﾠproposed	 ﾠsystem	 ﾠretrieves	 ﾠthe	 ﾠclinical	 ﾠ
records	 ﾠ from	 ﾠ the	 ﾠ various	 ﾠ source	 ﾠ systems.	 ﾠ The	 ﾠ unique	 ﾠ
contribution	 ﾠ of	 ﾠ our	 ﾠ system	 ﾠ is	 ﾠ the	 ﾠ collaborative	 ﾠ access	 ﾠ to	 ﾠ
self-ﾭ‐care	 ﾠsolutions	 ﾠthrough	 ﾠa	 ﾠCBR	 ﾠengine	 ﾠthat	 ﾠretrieves	 ﾠthe	 ﾠ
most	 ﾠ similar	 ﾠ problems-ﾭ‐solution-ﾭ‐outcome	 ﾠ triple	 ﾠ from	 ﾠ the	 ﾠ
most	 ﾠ similar	 ﾠ patient	 ﾠ record.	 ﾠ The	 ﾠ design	 ﾠ of	 ﾠ a	 ﾠ case	 ﾠ to	 ﾠ be	 ﾠ
represented	 ﾠand	 ﾠstored	 ﾠin	 ﾠthe	 ﾠCBR	 ﾠengine	 ﾠwas	 ﾠgiven	 ﾠa	 ﾠlot	 ﾠof	 ﾠ
consideration.	 ﾠ A	 ﾠ case	 ﾠ that	 ﾠ models	 ﾠ specific	 ﾠ features	 ﾠ or	 ﾠ
attributes	 ﾠ of	 ﾠ a	 ﾠ patient’s	 ﾠ health	 ﾠ state	 ﾠc a n 	 ﾠb e 	 ﾠs t o r e d 	 ﾠi n 	 ﾠ
different	 ﾠ representational	 ﾠ formats.
12-ﾭ‐15	 ﾠ The	 ﾠ case	 ﾠ features	 ﾠ
were	 ﾠchosen	 ﾠusing	 ﾠthe	 ﾠdata	 ﾠitems	 ﾠthat	 ﾠare	 ﾠavailable	 ﾠor	 ﾠcan	 ﾠ
be	 ﾠobtained.	 ﾠIn	 ﾠthe	 ﾠPHR	 ﾠenvironment,	 ﾠa	 ﾠpatient	 ﾠcan	 ﾠrecord	 ﾠ
data	 ﾠabout	 ﾠtheir	 ﾠdisease	 ﾠstage,	 ﾠcomplementary	 ﾠmedication	 ﾠ
and	 ﾠhealth	 ﾠoutcomes.	 ﾠThe	 ﾠdata	 ﾠstructures	 ﾠfor	 ﾠthe	 ﾠfeatures	 ﾠ
have	 ﾠto	 ﾠbe	 ﾠavailable	 ﾠor	 ﾠbe	 ﾠcapable	 ﾠof	 ﾠbeing	 ﾠtypes	 ﾠthat	 ﾠare	 ﾠ
available.
16	 ﾠT h e 	 ﾠf eatures	 ﾠ were	 ﾠ chosen	 ﾠ to	 ﾠ facilitate	 ﾠ an	 ﾠ
effective	 ﾠand	 ﾠefficient	 ﾠretrieval	 ﾠof	 ﾠcases	 ﾠstored	 ﾠin	 ﾠthe	 ﾠcase	 ﾠ
repository.	 ﾠ The	 ﾠ case-ﾭ‐base	 ﾠ was	 ﾠ built	 ﾠ using	 ﾠ features:	 ﾠ (i)	 ﾠ
current	 ﾠdisease	 ﾠstage;	 ﾠ(ii)	 ﾠcomplementary	 ﾠmedication;	 ﾠ(iii)	 ﾠ
outcome;	 ﾠ (iv)	 ﾠ outcome	 ﾠ method.	 ﾠ The	 ﾠ case-ﾭ‐base	 ﾠ was	 ﾠ
developed	 ﾠusing	 ﾠMySQL	 ﾠand	 ﾠthe	 ﾠinterface	 ﾠwas	 ﾠdeveloped	 ﾠ
using	 ﾠ motion	 ﾠ charts	 ﾠ in	 ﾠ Java	 ﾠ Script.	 ﾠ Figure	 ﾠ 1	 ﾠ shows	 ﾠ the	 ﾠ
interface	 ﾠof	 ﾠour	 ﾠresearch	 ﾠprototype.	 ﾠ
	 ﾠ
Figure	 ﾠ1:	 ﾠProposed	 ﾠsolution	 ﾠprototype	 ﾠwith	 ﾠa	 ﾠCBR	 ﾠengine	 ﾠ
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The	 ﾠcomputation	 ﾠof	 ﾠcase	 ﾠsimilarity	 ﾠis	 ﾠa	 ﾠkey	 ﾠaspect	 ﾠin	 ﾠCBR.	 ﾠ
The	 ﾠsimilarity	 ﾠis	 ﾠcomputed	 ﾠusing	 ﾠManhattan	 ﾠor	 ﾠ city	 ﾠ block	 ﾠ
distance	 ﾠ measure.
17	 ﾠ The	 ﾠ similarity	 ﾠ between	 ﾠ two	 ﾠ patient	 ﾠ
cases	 ﾠcan	 ﾠbe	 ﾠmeasured	 ﾠon	 ﾠan	 ﾠabsolute	 ﾠscale.	 ﾠManhattan	 ﾠor	 ﾠ
city-ﾭ‐block	 ﾠdistance	 ﾠmeasure	 ﾠis	 ﾠbased	 ﾠon	 ﾠthe	 ﾠabsolute	 ﾠvalues	 ﾠ
of	 ﾠthe	 ﾠcase	 ﾠfeatures.	 ﾠThe	 ﾠsimilarity	 ﾠmeasure	 ﾠis	 ﾠderived	 ﾠfrom	 ﾠ
the	 ﾠ method	 ﾠ of	 ﾠc o m p u t i n g 	 ﾠt h e 	 ﾠw a l k i n g 	 ﾠd i s t a n c e 	 ﾠb e t ween	 ﾠ
two	 ﾠ points	 ﾠ in	 ﾠ a	 ﾠ city	 ﾠ like	 ﾠ New	 ﾠ York’s	 ﾠ Manhattan	 ﾠ district	 ﾠ
where	 ﾠeach	 ﾠcomponent	 ﾠis	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠblocks	 ﾠin	 ﾠnorth-ﾭ‐
south	 ﾠ and	 ﾠ east-ﾭ‐west	 ﾠ directions.	 ﾠ The	 ﾠ formulation	 ﾠ for	 ﾠ the	 ﾠ
similarity	 ﾠbetween	 ﾠtwo	 ﾠpatient	 ﾠcases	 ﾠis	 ﾠmodelled	 ﾠas	 ﾠbelow:	 ﾠ
                                                                                                      
	 ﾠ	 ﾠ	 ﾠ	 ﾠ
	 ﾠ
	 ﾠ
Where	 ﾠdij	 ﾠis	 ﾠthe	 ﾠdistance	 ﾠbetween	 ﾠdata	 ﾠpoints	 ﾠin	 ﾠthe	 ﾠcase-ﾭ‐
base	 ﾠrelated	 ﾠto	 ﾠpatient	 ﾠcase.	 ﾠEach	 ﾠdata	 ﾠpoint	 ﾠcorresponds	 ﾠto	 ﾠ
the	 ﾠ value	 ﾠ of	 ﾠ the	 ﾠ features.	 ﾠ The	 ﾠ similarity	 ﾠ computation	 ﾠ
determines	 ﾠ the	 ﾠ most	 ﾠ similar	 ﾠ case	 ﾠ and	 ﾠ the	 ﾠ CBR	 ﾠ engine	 ﾠ
retrieves	 ﾠit	 ﾠfor	 ﾠsharing	 ﾠit	 ﾠwith	 ﾠend-ﾭ‐user.	 ﾠThe	 ﾠend-ﾭ‐user	 ﾠof	 ﾠour	 ﾠ
proposed	 ﾠsystem	 ﾠcould	 ﾠbe	 ﾠa	 ﾠpatient	 ﾠsearching	 ﾠfor	 ﾠoutcomes	 ﾠ
of	 ﾠcomplementary	 ﾠmedication	 ﾠreported	 ﾠby	 ﾠpatients	 ﾠon	 ﾠthe	 ﾠ
same	 ﾠ disease	 ﾠ age.	 ﾠ The	 ﾠ cases	 ﾠw e r e 	 ﾠm a t c h e d 	 ﾠu s i n g 	 ﾠt h e 	 ﾠ
feature	 ﾠvalues	 ﾠof	 ﾠcurrent	 ﾠdisease	 ﾠstage	 ﾠand	 ﾠcomplementary	 ﾠ
medication.	 ﾠ The	 ﾠ disease	 ﾠ stage	 ﾠ and	 ﾠ complementary	 ﾠ
medication	 ﾠare	 ﾠordinal	 ﾠvariables.	 ﾠ	 ﾠ
	 ﾠ
The	 ﾠfeatures	 ﾠused	 ﾠin	 ﾠour	 ﾠapproach	 ﾠare	 ﾠequally	 ﾠweighted	 ﾠfor	 ﾠ
the	 ﾠsimplicity	 ﾠof	 ﾠillustration	 ﾠof	 ﾠour	 ﾠprototype.	 ﾠThe	 ﾠweights	 ﾠ
associated	 ﾠwith	 ﾠthe	 ﾠfeatures	 ﾠcan	 ﾠbe	 ﾠdetermined	 ﾠby	 ﾠseveral	 ﾠ
PHR 
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methods	 ﾠand	 ﾠit	 ﾠis	 ﾠa	 ﾠseparate	 ﾠresearch	 ﾠquestion.	 ﾠThere	 ﾠcan	 ﾠ
be	 ﾠvarious	 ﾠapproaches	 ﾠfor	 ﾠdetermining	 ﾠweights	 ﾠassociated	 ﾠ
with	 ﾠthe	 ﾠfeatures	 ﾠin	 ﾠdata	 ﾠaggregation	 ﾠproblems	 ﾠespecially	 ﾠin	 ﾠ
the	 ﾠcontext	 ﾠof	 ﾠcase-ﾭ‐based	 ﾠreasoning.	 ﾠ	 ﾠ
	 ﾠ
The	 ﾠdescribed	 ﾠCBR	 ﾠapproach	 ﾠfacilitates	 ﾠthe	 ﾠretrieval	 ﾠof	 ﾠthe	 ﾠ
most	 ﾠsimilar	 ﾠpatient	 ﾠcase	 ﾠfor	 ﾠsharing	 ﾠit	 ﾠwith	 ﾠother	 ﾠpatients	 ﾠ
at	 ﾠthe	 ﾠsimilar	 ﾠdisease	 ﾠstage.	 ﾠThe	 ﾠvisual	 ﾠdata	 ﾠpresentation	 ﾠis	 ﾠ
based	 ﾠ on	 ﾠ the	 ﾠ changing	 ﾠ values	 ﾠ of	 ﾠ prostate-ﾭ‐specific	 ﾠ
antigen	 ﾠ(PSA)	 ﾠlevels	 ﾠover	 ﾠa	 ﾠgiven	 ﾠperiod	 ﾠin	 ﾠa	 ﾠline	 ﾠgraph	 ﾠon	 ﾠ
logarithmic	 ﾠ scale.	 ﾠ The	 ﾠ PSA	 ﾠ test	 ﾠ is	 ﾠ a	 ﾠ commonly	 ﾠ used	 ﾠ
diagnostic	 ﾠmeasure	 ﾠfor	 ﾠdetermining	 ﾠthe	 ﾠdisease	 ﾠprogression	 ﾠ
of	 ﾠ prostate	 ﾠ cancer.	 ﾠ The	 ﾠ other	 ﾠ key	 ﾠ information	 ﾠ such	 ﾠ as	 ﾠ
current	 ﾠtreatments,	 ﾠmedications	 ﾠis	 ﾠdisplayed	 ﾠon	 ﾠthe	 ﾠpatient	 ﾠ
journey	 ﾠ visual.	 ﾠ The	 ﾠ data	 ﾠ visualisation	 ﾠ assists	 ﾠ patients	 ﾠ in	 ﾠ
understanding	 ﾠ their	 ﾠ individual	 ﾠ disease	 ﾠ progression	 ﾠ
measured	 ﾠin	 ﾠPSA	 ﾠvalues.	 ﾠThe	 ﾠdata	 ﾠvisualisation	 ﾠalso	 ﾠassists	 ﾠ
patients	 ﾠ in	 ﾠ understanding	 ﾠ the	 ﾠ impact	 ﾠ of	 ﾠ treatments	 ﾠ at	 ﾠ
specific	 ﾠdisease	 ﾠstage.	 ﾠThe	 ﾠcare	 ﾠproviders	 ﾠcan	 ﾠalso	 ﾠuse	 ﾠthe	 ﾠ
proposed	 ﾠ visualisation	 ﾠ in	 ﾠ their	 ﾠ clinical	 ﾠ decision-ﾭ‐making	 ﾠ
process.	 ﾠ	 ﾠ	 ﾠ
	 ﾠ
The	 ﾠproposed	 ﾠapproach	 ﾠcould	 ﾠbenefit	 ﾠpatients	 ﾠin	 ﾠthe	 ﾠself-ﾭ‐
management	 ﾠ of	 ﾠ their	 ﾠ disease	 ﾠ conditions.	 ﾠ The	 ﾠ proposed	 ﾠ
system	 ﾠ may	 ﾠ provide	 ﾠ evidence	 ﾠ of	 ﾠ effectiveness	 ﾠ of	 ﾠ OTC	 ﾠ
complementary	 ﾠ medication	 ﾠ used	 ﾠ by	 ﾠ patients	 ﾠ at	 ﾠ similar	 ﾠ
disease	 ﾠ stages.	 ﾠ This	 ﾠ evidence	 ﾠ will	 ﾠ improve	 ﾠ patient	 ﾠ
education.	 ﾠ The	 ﾠ patients	 ﾠ may	 ﾠ learn	 ﾠ about	 ﾠ effective	 ﾠ
interventions	 ﾠ by	 ﾠ knowing	 ﾠ about	 ﾠ similar	 ﾠ patient	 ﾠ journeys.	 ﾠ
The	 ﾠ patients	 ﾠ may	 ﾠ also	 ﾠ use	 ﾠ the	 ﾠ proposed	 ﾠ system	 ﾠ to	 ﾠ
undertaken	 ﾠpreventative	 ﾠactions	 ﾠin	 ﾠconsultation	 ﾠwith	 ﾠtheir	 ﾠ
primary	 ﾠ clinicians.	 ﾠ The	 ﾠ proposed	 ﾠ solution	 ﾠ can	 ﾠ also	 ﾠ be	 ﾠ
integrated	 ﾠwith	 ﾠexisting	 ﾠsocial	 ﾠnetworks	 ﾠas	 ﾠpatients	 ﾠor	 ﾠusers	 ﾠ
with	 ﾠchronic	 ﾠconditions	 ﾠwill	 ﾠbe	 ﾠable	 ﾠto	 ﾠshare	 ﾠtheir	 ﾠspecific	 ﾠ
journey	 ﾠ with	 ﾠ other	 ﾠ users	 ﾠ of	 ﾠ their	 ﾠ choice.	 ﾠ The	 ﾠ proposed	 ﾠ
system	 ﾠ is	 ﾠ a	 ﾠ research	 ﾠ prototype	 ﾠ with	 ﾠ the	 ﾠ potential	 ﾠ to	 ﾠ
generate	 ﾠ new	 ﾠ evidence	 ﾠ of	 ﾠ effectiveness	 ﾠ of	 ﾠ specific	 ﾠ
interventions	 ﾠat	 ﾠeach	 ﾠhealth	 ﾠstate.	 ﾠA	 ﾠfull	 ﾠscale	 ﾠcommercial	 ﾠ
grade	 ﾠ development	 ﾠ and	 ﾠ evaluation	 ﾠ will	 ﾠ be	 ﾠ undertaken	 ﾠ in	 ﾠ
future.	 ﾠThe	 ﾠproposed	 ﾠapproach	 ﾠpresents	 ﾠa	 ﾠnew	 ﾠperspective	 ﾠ
of	 ﾠmodelling	 ﾠjourney	 ﾠof	 ﾠpatients	 ﾠwith	 ﾠchronic	 ﾠdiseases	 ﾠusing	 ﾠ
AI	 ﾠtechniques	 ﾠand	 ﾠdata	 ﾠdriven	 ﾠmethods.	 ﾠ	 ﾠ
	 ﾠ
Limitations	 ﾠ
The	 ﾠscope	 ﾠof	 ﾠthis	 ﾠresearch	 ﾠis	 ﾠlimited	 ﾠto	 ﾠadvanced	 ﾠprostate	 ﾠ
cancer	 ﾠpatients.	 ﾠThe	 ﾠdata	 ﾠcollection	 ﾠfrom	 ﾠa	 ﾠlarge	 ﾠnumber	 ﾠof	 ﾠ
patients	 ﾠwas	 ﾠchallenging	 ﾠdue	 ﾠto	 ﾠlimitations	 ﾠin	 ﾠreaching	 ﾠout	 ﾠ
to	 ﾠ advanced	 ﾠ prostate	 ﾠ cancer	 ﾠ patients.	 ﾠ Many	 ﾠ patients	 ﾠ did	 ﾠ
not	 ﾠattend	 ﾠthe	 ﾠpatient	 ﾠsupport	 ﾠgroups.	 ﾠThe	 ﾠpati ents	 ﾠwho	 ﾠ
participated	 ﾠin	 ﾠthe	 ﾠsurvey	 ﾠrepresent	 ﾠthe	 ﾠtarget	 ﾠpopulation	 ﾠof	 ﾠ
advanced	 ﾠprostate	 ﾠcancer	 ﾠpatients	 ﾠat	 ﾠa	 ﾠsmaller	 ﾠscale.	 ﾠThe	 ﾠ
scarcity	 ﾠof	 ﾠdata	 ﾠabout	 ﾠtreatment	 ﾠpatterns	 ﾠespecially	 ﾠduring	 ﾠ
advanced	 ﾠ stages	 ﾠ of	 ﾠ prostate	 ﾠ cancer	 ﾠ is	 ﾠ a	 ﾠ limitation	 ﾠ
encountered	 ﾠduring	 ﾠour	 ﾠresearch.	 ﾠThe	 ﾠchallenge	 ﾠin	 ﾠacquiring	 ﾠ
a	 ﾠ statistically	 ﾠ sufficient	 ﾠ sample	 ﾠ size	 ﾠ of	 ﾠ advanced	 ﾠ prostate	 ﾠ
cancer	 ﾠcan	 ﾠbe	 ﾠaddressed	 ﾠby	 ﾠbuilding	 ﾠa	 ﾠnational	 ﾠregistry	 ﾠof	 ﾠ
advanced	 ﾠ prostate	 ﾠ cancer	 ﾠ patient	 ﾠ data	 ﾠ for	 ﾠ research	 ﾠ
purposes.	 ﾠ We	 ﾠ acknowledge	 ﾠ that	 ﾠ methods	 ﾠ of	 ﾠ determining	 ﾠ
confidence	 ﾠ in	 ﾠ disease	 ﾠ stage	 ﾠ estimation	 ﾠ are	 ﾠ yet	 ﾠ to	 ﾠ be	 ﾠ
explored.	 ﾠWe	 ﾠpropose	 ﾠto	 ﾠaddress	 ﾠthis	 ﾠchallenge	 ﾠin	 ﾠfuture	 ﾠ
through	 ﾠa	 ﾠlarge	 ﾠscale	 ﾠstudy	 ﾠof	 ﾠthe	 ﾠproposed	 ﾠresearch.	 ﾠIt	 ﾠis	 ﾠ
anticipated	 ﾠthat	 ﾠthe	 ﾠlimitations	 ﾠspecified	 ﾠin	 ﾠthis	 ﾠpaper	 ﾠcan	 ﾠ
be	 ﾠaddressed	 ﾠin	 ﾠa	 ﾠlarge	 ﾠscale	 ﾠstudy.	 ﾠ	 ﾠ
	 ﾠ
Conclusion	 ﾠ
We	 ﾠshowed	 ﾠthat	 ﾠadvanced	 ﾠprostate	 ﾠcancer	 ﾠpatients	 ﾠuse	 ﾠa	 ﾠ
complementary	 ﾠmedication	 ﾠwhich	 ﾠsuggests	 ﾠa	 ﾠpattern	 ﾠof	 ﾠself-ﾭ‐
care	 ﾠamong	 ﾠthe	 ﾠpatients.	 ﾠThis	 ﾠstudy	 ﾠhas	 ﾠdescribed	 ﾠa	 ﾠCBR-ﾭ‐
based	 ﾠapproach	 ﾠto	 ﾠimprove	 ﾠself-ﾭ‐care	 ﾠfor	 ﾠadvanced	 ﾠprostate	 ﾠ
cancer	 ﾠpatients	 ﾠin	 ﾠan	 ﾠonline	 ﾠPHR	 ﾠenvironment.	 ﾠWe	 ﾠshowed	 ﾠ
that	 ﾠ a	 ﾠ technology-ﾭ‐based	 ﾠ intervention	 ﾠ can	 ﾠ improve	 ﾠ data	 ﾠ
access	 ﾠto	 ﾠadvanced	 ﾠprostate	 ﾠcancer	 ﾠpatients.	 ﾠA	 ﾠbasic	 ﾠversion	 ﾠ
of	 ﾠthe	 ﾠproposed	 ﾠsystem	 ﾠis	 ﾠbeing	 ﾠconsidered	 ﾠfor	 ﾠuse	 ﾠat	 ﾠan	 ﾠ
advanced	 ﾠprostate	 ﾠcancer	 ﾠmultidisciplinary	 ﾠteam	 ﾠclinic	 ﾠat	 ﾠa	 ﾠ
tertiary	 ﾠhospital	 ﾠin	 ﾠQueensland.	 ﾠ	 ﾠ
	 ﾠ
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